Drug - Adcirca (tadalafil) [United Therapeutics], Revatio (sildenafil) [Pfizer]
December 2009
Therapeutic area - Pulmonary Arterial Hypertension
Revatio or Adcirca is approved for use for pulmonary arterial hypertension.
Only one drug will be approved per patient.
Adcirca is subject to prescribing limits of two per day.
MHCP Provider Call Center 651-431-2700 or 800-366-5411
